
Blends
GLOW
Buy 2, get 1 free70mg
$89.99
Welcome to VANTA LABS
Are you 21 or older?
Vanta Labs supplies research materials for laboratory use only. You must be 21 or older to enter.
Research use only. Not for human or veterinary use.

KLOW is a four-component multi-peptide research blend combining GHK-Cu, KPV, BPC-157, and TB-500 (TB-4) in a single 80 mg lyophilized vial. Each component is documented individually by name and labelled quantity rather than merged into one undefined formulation. KLOW is supplied strictly for laboratory research use and is not intended for human or veterinary use, diagnosis, treatment, or administration of any kind.
Purity
99.271%
Batch
Vanta184290
Published batch records
Vanta184290
80 mg · 99.271% · Aug 24, 2026 · Kovera Labs
Frequently Asked Questions
KLOW is a four-component multi-peptide research blend from Vanta Labs, combining GHK-Cu, KPV, BPC-157, and TB-500 (TB-4) in a single 80 mg lyophilized vial for laboratory research use.
KLOW is a multi-peptide blend. It is not one chemical compound; it is four separately identified components combined in one vial.
KLOW includes GHK-Cu, KPV, BPC-157, and TB-500 (TB-4).
The four components in KLOW sum to a total labelled composition of 80 mg per vial.
KLOW contains 50 mg of GHK-Cu.
KLOW contains 10 mg of KPV.
KLOW contains 10 mg of BPC-157.
KLOW contains 10 mg of the component labelled TB-500 (TB-4).
The 80 mg figure is the sum of KLOW's four labelled component amounts: 50 mg GHK-Cu, 10 mg KPV, 10 mg BPC-157, and 10 mg TB-500 (TB-4).
According to the manufacturer's published documentation, KLOW contains an additional 10 mg KPV component that GLOW does not include. GLOW's listed composition is GHK-Cu 50 mg, BPC-157 10 mg, and TB-500 (TB-4) 10 mg, totaling 70 mg, while KLOW totals 80 mg with KPV added.
No. KLOW is sold strictly for laboratory research use and is not intended for human consumption, veterinary use, diagnosis, treatment, or administration of any kind.
No. All compounds sold by Vanta Labs are strictly for legitimate laboratory research purposes and are not intended for human or veterinary use.
Where a batch report has been published, the product page links to it. All published reports are in the COA Library, searchable by batch number.
In-stock orders placed before 2PM ET on a business day are dispatched the same day. Carrier transit time is additional. You will receive secure tracking information after dispatch.
No — exactly one discount applies per order. Promo codes, ambassador codes, bundle pricing, and promotions never combine. You don't have to figure out which is best: checkout automatically applies whichever single discount saves you the most.
Where we ship, damaged or missing items, returns and support are covered in our FAQ.
Related Products
KLOW is categorized at Vanta Labs as a Blend, meaning the vial contains four separately identified peptide components rather than one chemical entity. Each component carries its own name, its own labelled quantity, and, where applicable, its own chemical identifiers. Referring to KLOW as a single peptide misstates what is actually supplied: the product is a composite research material, and any identity or specification data for the vial as a whole should be read in that light.
| Component | Labelled Amount |
|---|---|
| GHK-Cu | 50 mg |
| KPV | 10 mg |
| BPC-157 | 10 mg |
| TB-500 (TB-4) | 10 mg |
| Total | 80 mg |
These are the quantities documented on the manufacturer's published blend composition and are not altered or rounded here.
The 80 mg nominal size printed on the product listing is the sum of the four labelled component amounts above (50 mg plus 10 mg plus 10 mg plus 10 mg). It describes the combined weight of the blend's identified components as supplied in the lyophilized vial, not a separately measured net-content figure from any individual analytical run.
GHK-Cu is the component present at the highest labelled amount in KLOW, at 50 mg. It is identified here by name and quantity only, as a constituent of the blend.
KPV is listed in KLOW at 10 mg. Like the other three components, it is documented individually within the blend rather than merged into an undifferentiated mixture.
BPC-157 is included in KLOW at a labelled amount of 10 mg, identified as a discrete component of the four-part composition.
The manufacturer's documentation labels the fourth component "TB-500 (TB-4)." This exact label is preserved here deliberately: the name TB-500 has been used in the research-peptide market for more than one peptide associated with thymosin beta-4, and no single amino acid sequence is asserted for this component on this page. Readers comparing KLOW across sources should rely on the labelled name and quantity rather than assuming a fixed molecular identity behind the TB-500 designation.
KLOW ships as a lyophilized (freeze-dried) powder in a single vial. Lyophilization is a standard laboratory preservation format for peptide materials and is noted here only as a description of physical form, not as guidance for reconstitution, storage, or use.
According to the manufacturer's published documentation, KLOW and GLOW share three components at the same labelled amounts (GHK-Cu 50 mg, BPC-157 10 mg, TB-500 (TB-4) 10 mg), but KLOW adds a fourth component, KPV, at 10 mg. That brings KLOW's total to 80 mg against GLOW's 70 mg. This is stated here only as a factual composition difference, not as a comparison of effects.
| Field | Specification |
|---|---|
| Product name | KLOW |
| Category | Blends |
| Product size | 80 mg |
| Supplied form | Lyophilized powder |
| Packaging | 1 vial |
| Component 1 | GHK-Cu, 50 mg |
| Component 2 | KPV, 10 mg |
| Component 3 | BPC-157, 10 mg |
| Component 4 | TB-500 (TB-4), 10 mg |
| Total nominal composition | 80 mg |
| Research classification | Research Use Only |
No single CAS number, molecular formula, molecular weight, or peptide sequence is assigned to KLOW as a whole, because the vial contains four distinct components rather than one compound. Identity data for an individual component, where published and independently verifiable, should be sourced and documented separately from this blend-level specification.
The published analytical report for KLOW's blend was generated using reversed-phase HPLC (RP-HPLC) for purity analysis and LC-MS for identity confirmation. These are standard methods for assessing peptide blend material and are referenced here only to the extent the underlying report documents them. The purity figure associated with that report is a blend-level figure and should not be read as a confirmed value for each individual component, or assumed to apply automatically to every future batch of KLOW. Reported methods and figures describe the blend as tested; they are not a guarantee of identical figures on retesting, and any batch-specific figure shown elsewhere on this page takes precedence over general descriptions here.
Each batch of KLOW is intended to carry its own Certificate of Analysis, accessible through the COA library. The specific batch number, test date, laboratory name, and purity percentage for the current batch are shown dynamically on this page and in the linked COA rather than typed into this description, so the figures displayed always match the batch actually documented. For background on reading these documents, see how to read a COA and purity and third-party testing. If a reported net content figure differs from the 80 mg nominal label, treat the two as separate measurements: the nominal label states the intended composition, while a net content figure reflects what a specific analytical run measured.
KLOW, including each of its four labelled components (GHK-Cu, KPV, BPC-157, and TB-500 (TB-4)), is sold exclusively for in-vitro laboratory research. It is not a drug, dietary supplement, cosmetic, or medical device, and it has not been evaluated by any regulatory body for human or animal use. KLOW is not intended to diagnose, treat, cure, or prevent any disease, and no statement on this page should be interpreted as medical, veterinary, or health guidance. Purchasers are responsible for ensuring that their use of KLOW complies with all applicable laws and institutional regulations governing laboratory research materials. For additional detail, see the research use disclaimer.
Blog
Store reviews · ordering, shipping and service
5.0 average customer rating
“Ordered on a Wednesday morning and wasn't expecting much because it was my first time buying here. Got tracking that afternoon and the package arrived Friday. Honestly faster than I expected lol.”
Vanta Labs customer
“Not gonna lie I accidentally added the wrong item to my cart and didn't realize until after checkout. Sent a message thinking I'd be stuck with it. Support helped me correct it before the package went out. Saved me a headache.”
Vanta Labs customer
“The packaging was actually what impressed me most. I've had glass research supplies arrive with barely any protection before, so seeing everything packed properly was a relief. Little things like that matter.”
Vanta Labs customer
“First time ordering here. The site was easy enough to use, although I had to go back and double check which size I selected. Everything was labeled clearly when it arrived.”
Vanta Labs customer
“Honestly I spent more time comparing options than I did checking out lol. Once I decided what I wanted, the actual order process took maybe two minutes.”
Vanta Labs customer
“Placed an order after a friend mentioned the website. I was a little skeptical because I hadn't heard of them before, but the ordering experience was straightforward and the communication was good. Everything came fast and will buy again.”
Vanta Labs customer
Sent to us by customers by email; names withheld. Reviews describe ordering, shipping and service.
Compound
Specifications
| Component | Labeled amount |
|---|---|
| GHK-Cu | 50 mg |
| KPV | 10 mg |
| BPC-157 | 10 mg |
| TB-500 (TB-4) | 10 mg |
As labeled on batch report KVR-2026-E355F5.
CAS numbers, molecular formulas, molecular weights, and sequences are not assigned to KLOW as a whole because it is a four-component blend, not one chemical entity. Verified identifiers for an individual component should be sourced and documented separately rather than applied to the blend record.
Testing
Certificates of Analysis for the batch currently supplied. Each report is the laboratory's own document for that vial size.
KVR-2026-E355F5 · 80 mg
Blend average purity 99.271% (RP-HPLC, C18 column, DAD detection at 214 nm) · Identity by LC-MS · Certified Aug 24, 2026 · Kovera Labs
Access code 04APW3P
Kovera Labs reports can be checked with the laboratory: enter the report number and access code at koveralabs.com/verify.
Browse the COA LibraryOrdering: Shipping policy · Returns and reimbursement · Research use disclaimer